Larry Lambertson
Psychiatry · Fort Wayne, INNPI 1124019005
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $135,016 of the $208,150 with a category attached, or 64.9%. E.r. Squibb & Sons, L.L.C. accounts for 82.6% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $115,413, 3.6 times the $32,109 reported in 2019. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 429 payments — averaging $485.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$172K
- Alkermes, Inc.$13K
- Otsuka America Pharmaceutical, Inc.$12K
- Sunovion Pharmaceuticals Inc.$8K
- AbbVie$616
- Axsome Therapeutics, Inc.$607
- plus $2K from 12 others
What the payments were for
- Consulting fees$38,34518%
- Speaking & faculty fees$135,01665%
- Travel & lodging$24,47612%
- Food & beverage$10,1695%
- Education$1440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 173 | $172,010 |
| Alkermes, Inc. | 31 | $13,232 |
| Otsuka America Pharmaceutical, Inc. | 37 | $11,934 |
| Sunovion Pharmaceuticals Inc. | 32 | $7,744 |
| AbbVie | 46 | $616 |
| Axsome Therapeutics, Inc. | 23 | $607 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $520 |
| Johnson & Johnson | 18 | $302 |
| Supernus Pharmaceuticals, Inc. | 10 | $291 |
| Neurocrine Biosciences, Inc. | 7 | $220 |
| Teva Pharmaceuticals USA, Inc. | 6 | $200 |
| Lundbeck LLC | 17 | $165 |
| Idorsia Pharmaceuticals US Inc | 1 | $107 |
| Vanda Pharmaceuticals Inc. | 5 | $103 |
| Indivior Inc. | 2 | $35 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Biogen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COBENFY$111,898
- ARISTADA$50,492
- ARISTADA INITIO$12,623
- ABILIFY MAINTENA$10,989
- LATUDA$7,423
- ABILIFY ASIMTUFII$579
- Auvelity$336
- VRAYLAR$234
- CAPLYTA$234
- REXULTI$234
- UZEDY$121
- INGREZZA$121
- QELBREE$119
- SPRAVATO$112
- QUVIVIQ$107
How this compares
$208,150 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 71 | $609,802 |
| Invega SustennaPaliperidone Palmitate | 137 | $449,214 |
| VraylarCariprazine Hcl | 163 | $243,946 |
| AustedoDeutetrabenazine | 38 | $232,620 |
| Abilify MaintenaAripiprazole | 59 | $174,027 |
| RexultiBrexpiprazole | 106 | $161,078 |
| Invega TrinzaPaliperidone Palmitate | 14 | $153,159 |
| AristadaAripiprazole Lauroxil | 24 | $78,969 |
| AuvelityDextromethorphan Hbr/Bupropion | 82 | $78,748 |
| LybalviOlanzapine/Samidorphan Malate | 80 | $60,761 |
| CobenfyXanomeline Tart/Trospium Chlor | 44 | $46,294 |
| Wellbutrin XlBupropion Hcl | 19 | $45,490 |
| PerserisRisperidone | 13 | $41,703 |
| CaplytaLumateperone Tosylate | 33 | $41,391 |
| Risperdal ConstaRisperidone Microspheres | 25 | $31,783 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $302 | $634,156176 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $220 | $609,80271 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $11,934 | $335,105165 claims |
| AbbVieVraylar | $616 | $243,946163 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $200 | $232,62038 claims |
| Alkermes, Inc.Aristada, Lybalvi, Vivitrol | $13,232 | $167,317121 claims |
| Axsome Therapeutics, Inc.Auvelity | $607 | $78,74882 claims |
| E.r. Squibb & Sons, L.L.C.Cobenfy | $172,010 | $46,29444 claims |
| Indivior Inc.Perseris | $35 | $41,70313 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $520 | $41,39133 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $103 | $13,88313 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $291 | $6,72324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Fort Wayne
- Prevesh RustagiFort Wayne$64K
- Mahender SurakantiFort Wayne$13K
- Geeta BishtFort Wayne$11K
- Andrea NaaumFort Wayne$8K
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.